Boston, United States
Cellular Intelligence, previously known as Somite AI, is a cutting-edge AI-native TechBio startup based in the United States. Established in 2023, the company is spearheading innovation in the fields of AI and Biotechnology by developing the first universal virtual cell-signaling model. This groundbreaking model aims to decode and control cellular communication, opening doors to new horizons in regenerative medicine, drug response prediction, and disease mechanism modeling.
Utilizing their proprietary capsule technology, Cellular Intelligence enhances cellular data generation efficiency by over 1,000 times compared to traditional methods, enabling the creation of large-scale predictive models.
With backing of more than $62 million from prestigious investors like Khosla Ventures and the Chan Zuckerberg Initiative, the company received a significant $47 million Series A investment on May 13, 2025, featuring participants such as Fusion Fund, SciFi VC, TechAviv, and others.
